📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Halo Pharma

1.1 - Company Overview

Halo Pharma Logo

Halo Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of contract dosage form development, manufacturing, and testing services to the pharmaceutical, biotechnology, and generic industries. Services include product development to commercial manufacturing; formulation and analytical development; clinical manufacturing and packaging; solid dosage production (tablets, capsules, powders, granules, micro-tablets, multi-particulates), and clinical supplies for liquids, suspensions, and powder-in-bottle.

Products and services

  • Analytical Development: Develops pre-clinical–Phase III analytical methods with method development and validation support, maintaining testing continuity from early studies through Phase III
  • Formulation Development: Architects QbD-driven programs including excipient compatibility studies, pre-formulation, formulation, and Quality by Design activities for dosage forms
  • Product Development and Commercial Manufacturing: Delivers integrated processes that transfer products from proof-of-concept to commercialization, coordinating dosage form development and manufacturing steps across programs

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Halo Pharma

Doppel Farmaceutici Logo

Doppel Farmaceutici

HQ: Italy Website
  • Description: Provider of contract development and manufacturing for pharmaceutical and nutritional products, covering formulation, development, manufacturing, packaging, marketing and post-marketing controls. Delivers R&D for formulation/analytical methods, clinical trial batches and regulatory consultancy. Manufactures solids, semi-solids, liquids, sprays, sterile products, injectables, medical devices, soft gelatin capsules, highly potent drugs, and food/effervescent supplements.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Doppel Farmaceutici company profile →
Aceto Logo

Aceto

HQ: United States Website
  • Description: Provider of niche, differentiated specialty materials for life sciences and advanced technology end markets; a global virtual manufacturer operating in nine countries, distributing over 1,100 chemical compounds used by pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aceto company profile →
SFL Logo

SFL

HQ: Switzerland Website
  • Description: Provider of integrated consultancy solutions to pharma, biotech and medtech companies for global and local activities, with in-house expertise across product life cycle functions including Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, and Medical Writing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SFL company profile →
Konapharma Logo

Konapharma

HQ: Switzerland Website
  • Description: Provider of contract manufacturing services specializing in the production of solid dosage forms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Konapharma company profile →
Acurian Logo

Acurian

HQ: United States Website
  • Description: Provider of patient and doctor recruitment, enrollment and retention solutions for clinical trials, including recruitment feasibility, site identification and selection, data-driven patient recruitment, an integrated network for AES research sites, geo-targeted vaccine volunteer enrollment via a global site network, specialized strategies for challenging indications (Alzheimer's, NASH), and cancer solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acurian company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Halo Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Halo Pharma

2.2 - Growth funds investing in similar companies to Halo Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Halo Pharma

4.2 - Public trading comparable groups for Halo Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Halo Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Halo Pharma

What does Halo Pharma do?

Halo Pharma is a provider of contract dosage form development, manufacturing, and testing services to the pharmaceutical, biotechnology, and generic industries. Services include product development to commercial manufacturing; formulation and analytical development; clinical manufacturing and packaging; solid dosage production (tablets, capsules, powders, granules, micro-tablets, multi-particulates), and clinical supplies for liquids, suspensions, and powder-in-bottle.

Who are Halo Pharma's competitors?

Halo Pharma's competitors and similar companies include Doppel Farmaceutici, Aceto, SFL, Konapharma, and Acurian.

Where is Halo Pharma headquartered?

Halo Pharma is headquartered in United States.

How many employees does Halo Pharma have?

Halo Pharma has 1,000 employees 🔒.

When was Halo Pharma founded?

Halo Pharma was founded in 2010 🔒.

What sector and industry vertical is Halo Pharma in?

Halo Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Halo Pharma

Who are the top strategic acquirers in Halo Pharma's sector and industry

Top strategic M&A buyers and acquirers in Halo Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Halo Pharma?

Top strategic M&A buyers groups and sectors for Halo Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Halo Pharma's sector and industry vertical

Which are the top PE firms investing in Halo Pharma's sector and industry vertical?

Top PE firms investing in Halo Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Halo Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Halo Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Halo Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Halo Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Halo Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Halo Pharma?

The key public trading comparables and valuation benchmarks for Halo Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Halo Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Halo Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Halo Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Halo Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Halo Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Halo Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Halo Pharma

Launch login modal Launch register modal